Friday, September 6, 2013

Mallinckrodt's extended-release pain drug meets main goal of study

Retweeted Medical News (@MedicalNews): Mallinckrodt's extended-release pain drug meets main goal of study http://t.co/nxwoz78rRz

via VAT ENGPlus Combo | VATPlus | MotionTrak http://t.co/nxwoz78rRz

No comments:

Post a Comment